Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Leo L Wang; Megan H Noe; Robert G Micheletti

doi:10.1001/jamadermatol.2022.3011

Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

JAMA Dermatol. 2022 Oct 1;158(10):1212-1214. doi: 10.1001/jamadermatol.2022.3011.

Authors

Leo L Wang¹, Megan H Noe², Robert G Micheletti¹

Affiliations

¹ Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

Plain language summary

This case series compares the factors, comorbidities, and complications associated with leukopenia between patients with and without leukopenia on hospital admission.

MeSH terms

Humans
Leukopenia* / complications
Leukopenia* / etiology
Prevalence
Stevens-Johnson Syndrome* / complications
Stevens-Johnson Syndrome* / epidemiology
Thrombocytopenia*